Pegylated Liposomal Doxorubicin: A Guide to Its Use in Various Malignancies
Pegylated Liposomal Doxorubicin: A Guide to Its Use in Various Malignancies
About this item
Full title
Author / Creator
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
Pegylated liposomal doxorubicin (Caelyx
®
[EU], Doxil
®
[USA]) represents an improved formulation of conventional doxorubicin, with reduced cardiotoxicity and an improved pharmacokinetic profile. As shown by evidence from clinical trials, intravenous pegylated liposomal doxorubicin is a useful option in the treatment of various malignan...
Alternative Titles
Full title
Pegylated Liposomal Doxorubicin: A Guide to Its Use in Various Malignancies
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1500789723
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1500789723
Other Identifiers
ISSN
1173-8804
E-ISSN
1179-190X
DOI
10.1007/s40259-013-0070-1
